Literature DB >> 3134807

Cranial MR imaging in neurofibromatosis.

J R Bognanno1, M K Edwards, T A Lee, D W Dunn, K L Roos, E C Klatte.   

Abstract

Cranial MR images of 53 patients with neurofibromatosis were reviewed to determine the nature, extent, and number of intracranial abnormalities present. All patients studied met tentative definitions established for the diagnosis of neurofibromatosis. Twenty-three were scanned for evaluation of known CNS of cranial nerve involvement; the remainder were neurologically asymptomatic patients without suspected lesions referred for screening. Single lesions were noted in 32 patients. Multiple lesions were identified in 14 patients. Seven had normal scans. In 23 patients small focal areas of increased signal on T2-weighted scans within the brain were though to represent heterotopias. Eight patients had chiasmal gliomas and two had optic nerve gliomas. Nine patients had parenchymal gliomas, two had ischemic changes, and one had a colloid cyst. Extraaxial lesions included acoustic neuromas (five patients), meningiomas (four), trigeminal neurofibromas (one), and dysplasia of a sphenoid wing (two). Of the 30 asymptomatic patients referred for screening, lesions were found in 23. MR was found to be an excellent method of imaging known disease and of detecting lesions in asymptomatic patients. Because of the large number of asymptomatic lesions detected in this population, a screening MR study is recommended in patients with neurofibromatosis.

Entities:  

Mesh:

Year:  1988        PMID: 3134807     DOI: 10.2214/ajr.151.2.381

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  20 in total

1.  CT detection of basal ganglion lesions in neurofibromatosis type 1: correlation with MRI.

Authors:  F Menor; L Marti-Bonmatí
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

2.  The neurosurgical aspects of neurofibromatosis 2: diagnosis and management.

Authors:  M Turgut; S Palaoğlu; O E Ozcan
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

3.  MR imaging of the corpus callosum in pediatric patients with neurofibromatosis type 1.

Authors:  E C Dubovsky; T N Booth; G Vezina; C A Samango-Sprouse; K M Palmer; C O Brasseux
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

Review 4.  Guidelines for the diagnosis and management of individuals with neurofibromatosis 1.

Authors:  Rosalie E Ferner; Susan M Huson; Nick Thomas; Celia Moss; Harry Willshaw; D Gareth Evans; Meena Upadhyaya; Richard Towers; Michael Gleeson; Christine Steiger; Amanda Kirby
Journal:  J Med Genet       Date:  2006-11-14       Impact factor: 6.318

5.  Bony orbital morphology in neurofibromatosis type 1 (NF1).

Authors:  S C Kaste; E K Pivnick
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

6.  Radiological investigation of neurofibromatosis type 2.

Authors:  P Akeson; S Holtås
Journal:  Neuroradiology       Date:  1994       Impact factor: 2.804

Review 7.  Gastrointestinal and retroperitoneal manifestations of type 1 neurofibromatosis.

Authors:  Ursula Basile; Giuseppe Cavallaro; Andrea Polistena; Sandra Giustini; Gennaro Orlando; Dario Cotesta; Luigi Petramala; Claudio Letizia; Stefano Calvieri; Giorgio De Toma
Journal:  J Gastrointest Surg       Date:  2010-01       Impact factor: 3.452

8.  Central nervous system imaging in reevaluation of patients with neurofibromatosis type 1.

Authors:  P Balestri; L Calistri; R Vivarelli; G Bartalini; L Mancini; A Berardi; A Fois
Journal:  Childs Nerv Syst       Date:  1993-12       Impact factor: 1.475

9.  Cerebral glucose metabolism in neurofibromatosis type 1 assessed with [18F]-2-fluoro-2-deoxy-D-glucose and PET.

Authors:  P Balestri; G Lucignani; A Fois; L Magliani; L Calistri; C Grana; R M Di Bartolo; D Perani; F Fazio
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-12       Impact factor: 10.154

10.  Imaging considerations of central nervous system manifestations in pediatric patients with neurofibromatosis type 1.

Authors:  F Menor; L Martí-Bonmatí; F Mulas; H Cortina; R Olagüe
Journal:  Pediatr Radiol       Date:  1991
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.